Serving all people by providing personalized health and wellness through exemplary care, education and research.
Explore health content from A to Z.
I need information about...
Allogeneic islet cell transplant - an experimental protocol - aims specifically at patients with long-term disease who have difficulty controlling their blood sugar.
In patients with type 1 diabetes, islet cells from a deceased donor are extracted and then infused into the patient's liver, where they may be able to produce insulin.
Successful allo islet cell transplantation may represent a pivotal development in diabetes management, potentially providing patients with better blood glucose control.
Typical candidates for allo islet cell transplantation at Baylor have:
Islet cell transplantation for diabetes is still considered experimental and can only be conducted at approved centers like Baylor, which is equipped with a FDA approved islet cell processing facility and well-trained clinicians to handle complex and long-term medical needs of transplant patients.
Copyright © 2016 Baylor Scott & White Health. All Rights Reserved. |
3500 Gaston Ave., Dallas, TX 75246-2017 | 1.800.4BAYLOR
Privacy and Patient Rights |
Notice of Non-Discrimination |
Site Map | Contact Us